Key facts
- This page summarizes South Cone Investments Limited Partnership's Form 4 filing for Rani Therapeutics Holdings, Inc. (RANI).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 22 Oct 2025, 18:57.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Sale
Additional SEC filing notes
Section 16 status
South Cone Investments Limited Partnership is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Footnote F1
The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.25 to $2.61, inclusive. The reporting person undertakes to provide to Rani Therapeutics Holdings, Inc. ("Rani"), any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Footnote F2
South Cone Investments Limited Partnership directly owns 100% of the issued and outstanding membership interest of South Lake One LLC.
Footnote F3
The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.50 to $3.09, inclusive. The reporting person undertakes to provide to Rani, any security holder of Rani, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.